ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
The human factor in licensing and operating the next generation of nuclear plants
As human factors specialists working at the intersection of human performance and nuclear operations, we are witnessing one of the nuclear sector’s most significant transitions in decades. The emergence of small modular reactors, microreactors, and other advanced designs is reshaping the industry’s landscape. Digital instrumentation and controls, passive safety systems, and increased automation are creating opportunities for greater safety margins and more flexible operation. These same features also fundamentally redefine what it means to “operate” a nuclear plant. Interactions among human roles, automation, and passive systems shape how people maintain awareness, exercise judgment, and intervene when necessary. These developments affect both operational realities and the regulatory foundations on which nuclear safety is built.
Florent Martinetti, Laurent Donadille, Sabine Delacroix, Catherine Nauraye, Aurélien De Oliveira, Joël Herault, Isabelle Clairand
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 721-727
Proton Therapy | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9296
Articles are hosted by Taylor and Francis Online.
A Monte Carlo modeling tool was applied at the Institut-Curie Centre de Protonthérapie d'Orsay, France, to simulate the passively scattered beam line used for treatment of ocular melanoma. The primary aim of this study is to validate the model for subsequent calculation of patient doses due to secondary neutrons.The Monte Carlo code MCNPX is used here to model the geometry of the beam line. The beam parameters at the entrance of the ophthalmologic beam line are not well known (beam emittance, lateral distribution, and energy spread). Hence, to accurately implement the beam source in the model, we need to calculate and measure these parameters in the first step of this study. Then, we perform comparisons between calculated and measured proton absorbed dose profiles under various scattering conditions.Comparisons between calculated and measured depth versus dose profiles show discrepancies <0.6 mm (range) and <1.1 mm (beam size and penumbra) for the lateral dose profiles. Hence, calculated relative dose profiles are considered to be correctly described by the Monte Carlo model. Some improvements are still needed to reproduce absolute dose profiles. This study should lead to the use of the numerical model for radiation protection applications.